Home
About us
Pipeline
News
Contact
DISCOVERY.
Translating cancer science into novel immunotherapies
SCIENCE.
Reveal unexplored regulators of anticancer immunity
Latest news and report
24 February 2023
IPH5201 (CD39 mAb): initiation of Phase 2 clinical trial MATISSE
Read more
23 December 2022
Happy holidays and Merry Christmas !
Read more
6 December 2022
OREGA enters into a License Agreement with Genmab
Read more
20 October 2022
37th SITC annual meeting 2022
Read more
3 June 2022
PRESS RELEASE – IPH5201 (CD39 mAb) to advance into Phase 2
Read more
4 April 2022
AACR annual meeting 2022
Read more
4 February 2022
World Cancer Day
Read more
18 December 2020
Armand Bensussan awarded the Galien Prize 2020
Read more
